Haemophagocytic lymphohistiocytosis associated with immune checkpoint inhibitors: a descriptive case study and literature review
Gespeichert in:
| Veröffentlicht in: | British journal of haematology 2020-06, Vol.189 (5), p.985-992 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 992 |
|---|---|
| container_issue | 5 |
| container_start_page | 985 |
| container_title | British journal of haematology |
| container_volume | 189 |
| creator | Dupré, Anastasia Michot, Jean‐Marie Schoeffler, Amélie Frumholtz, Laure Baroudjian, Barouyr Delyon, Julie Lebbe, Céleste Lambotte, Olivier |
| description | |
| doi_str_mv | 10.1111/bjh.16630 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_wiley</sourceid><recordid>TN_cdi_wiley_primary_10_1111_bjh_16630_BJH16630</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2409627550</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3880-79de615f21f432b892595644898716ed5c241531173ef0a97dc47bb1de868c8a3</originalsourceid><addsrcrecordid>eNqN0U2P0zAQBmALgdiycOAPIEucEOquPxOHG1QsBa3EBc6R40zIlCYOtrNVbvx03G3ZGxJzsWQ9Mx69JuQlZ1c813Wz6694UUj2iKy4LPRacMUfkxVjrFxzpswFeRbjjjEumeZPyYUUQkldmhX5vbUw-Km3P7xbEjq6X4ap9z3GhMcbHzFSG6N3aBO09ICppzgM8wjU9eB-Th7HRHHsscHkQ3xHLW0huoBTwruMbAQa09wu1I4t3WOCYNMcgAa4Qzg8J086u4_w4nxeku83H79ttuvbr58-b97frp00hq3LqoWC607wTknRmEroShdKmcqUvIBWO6G4lpyXEjpmq7J1qmwa3oIpjDNWXpLXp7lT8L9miKne-TmM-claKFYVotSaZfXmpFzwMQbo6ingYMNSc1Yfs65z1vV91tm-Ok-cmwHaB_k33AzensABGt9FhzA6eGD5c7SQQpXsWDxr8_96g8nmDxo3fh5Tbr0-t-Ieln-vXH_4sj3t_gf1hqsx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2409627550</pqid></control><display><type>article</type><title>Haemophagocytic lymphohistiocytosis associated with immune checkpoint inhibitors: a descriptive case study and literature review</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Free Content</source><creator>Dupré, Anastasia ; Michot, Jean‐Marie ; Schoeffler, Amélie ; Frumholtz, Laure ; Baroudjian, Barouyr ; Delyon, Julie ; Lebbe, Céleste ; Lambotte, Olivier</creator><creatorcontrib>Dupré, Anastasia ; Michot, Jean‐Marie ; Schoeffler, Amélie ; Frumholtz, Laure ; Baroudjian, Barouyr ; Delyon, Julie ; Lebbe, Céleste ; Lambotte, Olivier</creatorcontrib><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/bjh.16630</identifier><identifier>PMID: 32243578</identifier><language>eng</language><publisher>HOBOKEN: Wiley</publisher><subject>Adult ; Antibodies, Monoclonal, Humanized - adverse effects ; Antibodies, Monoclonal, Humanized - therapeutic use ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Combined Modality Therapy ; Fatal Outcome ; Female ; France - epidemiology ; haematotoxicity ; haemophagocytic lymphohistiocytosis ; Hematology ; Humans ; Immune checkpoint ; Immune Checkpoint Inhibitors - adverse effects ; Immune Checkpoint Inhibitors - therapeutic use ; Immunotherapy - adverse effects ; Ipilimumab - adverse effects ; Ipilimumab - therapeutic use ; Life Sciences & Biomedicine ; Literature reviews ; Lymphohistiocytosis, Hemophagocytic - chemically induced ; Lymphohistiocytosis, Hemophagocytic - epidemiology ; Male ; Middle Aged ; Neoplasms - drug therapy ; Nivolumab - adverse effects ; Nivolumab - therapeutic use ; Science & Technology ; tumour immunotherapy</subject><ispartof>British journal of haematology, 2020-06, Vol.189 (5), p.985-992</ispartof><rights>2020 British Society for Haematology and John Wiley & Sons Ltd</rights><rights>Copyright © 2020 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>26</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000523247000001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c3880-79de615f21f432b892595644898716ed5c241531173ef0a97dc47bb1de868c8a3</citedby><cites>FETCH-LOGICAL-c3880-79de615f21f432b892595644898716ed5c241531173ef0a97dc47bb1de868c8a3</cites><orcidid>0000-0001-7201-6456 ; 0000-0003-3482-3331 ; 0000-0002-4557-3377</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbjh.16630$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbjh.16630$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,1428,27905,27906,45555,45556,46390,46814</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32243578$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dupré, Anastasia</creatorcontrib><creatorcontrib>Michot, Jean‐Marie</creatorcontrib><creatorcontrib>Schoeffler, Amélie</creatorcontrib><creatorcontrib>Frumholtz, Laure</creatorcontrib><creatorcontrib>Baroudjian, Barouyr</creatorcontrib><creatorcontrib>Delyon, Julie</creatorcontrib><creatorcontrib>Lebbe, Céleste</creatorcontrib><creatorcontrib>Lambotte, Olivier</creatorcontrib><title>Haemophagocytic lymphohistiocytosis associated with immune checkpoint inhibitors: a descriptive case study and literature review</title><title>British journal of haematology</title><addtitle>BRIT J HAEMATOL</addtitle><addtitle>Br J Haematol</addtitle><subject>Adult</subject><subject>Antibodies, Monoclonal, Humanized - adverse effects</subject><subject>Antibodies, Monoclonal, Humanized - therapeutic use</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Combined Modality Therapy</subject><subject>Fatal Outcome</subject><subject>Female</subject><subject>France - epidemiology</subject><subject>haematotoxicity</subject><subject>haemophagocytic lymphohistiocytosis</subject><subject>Hematology</subject><subject>Humans</subject><subject>Immune checkpoint</subject><subject>Immune Checkpoint Inhibitors - adverse effects</subject><subject>Immune Checkpoint Inhibitors - therapeutic use</subject><subject>Immunotherapy - adverse effects</subject><subject>Ipilimumab - adverse effects</subject><subject>Ipilimumab - therapeutic use</subject><subject>Life Sciences & Biomedicine</subject><subject>Literature reviews</subject><subject>Lymphohistiocytosis, Hemophagocytic - chemically induced</subject><subject>Lymphohistiocytosis, Hemophagocytic - epidemiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasms - drug therapy</subject><subject>Nivolumab - adverse effects</subject><subject>Nivolumab - therapeutic use</subject><subject>Science & Technology</subject><subject>tumour immunotherapy</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><sourceid>EIF</sourceid><recordid>eNqN0U2P0zAQBmALgdiycOAPIEucEOquPxOHG1QsBa3EBc6R40zIlCYOtrNVbvx03G3ZGxJzsWQ9Mx69JuQlZ1c813Wz6694UUj2iKy4LPRacMUfkxVjrFxzpswFeRbjjjEumeZPyYUUQkldmhX5vbUw-Km3P7xbEjq6X4ap9z3GhMcbHzFSG6N3aBO09ICppzgM8wjU9eB-Th7HRHHsscHkQ3xHLW0huoBTwruMbAQa09wu1I4t3WOCYNMcgAa4Qzg8J086u4_w4nxeku83H79ttuvbr58-b97frp00hq3LqoWC607wTknRmEroShdKmcqUvIBWO6G4lpyXEjpmq7J1qmwa3oIpjDNWXpLXp7lT8L9miKne-TmM-claKFYVotSaZfXmpFzwMQbo6ingYMNSc1Yfs65z1vV91tm-Ok-cmwHaB_k33AzensABGt9FhzA6eGD5c7SQQpXsWDxr8_96g8nmDxo3fh5Tbr0-t-Ieln-vXH_4sj3t_gf1hqsx</recordid><startdate>202006</startdate><enddate>202006</enddate><creator>Dupré, Anastasia</creator><creator>Michot, Jean‐Marie</creator><creator>Schoeffler, Amélie</creator><creator>Frumholtz, Laure</creator><creator>Baroudjian, Barouyr</creator><creator>Delyon, Julie</creator><creator>Lebbe, Céleste</creator><creator>Lambotte, Olivier</creator><general>Wiley</general><general>Blackwell Publishing Ltd</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><orcidid>https://orcid.org/0000-0001-7201-6456</orcidid><orcidid>https://orcid.org/0000-0003-3482-3331</orcidid><orcidid>https://orcid.org/0000-0002-4557-3377</orcidid></search><sort><creationdate>202006</creationdate><title>Haemophagocytic lymphohistiocytosis associated with immune checkpoint inhibitors: a descriptive case study and literature review</title><author>Dupré, Anastasia ; Michot, Jean‐Marie ; Schoeffler, Amélie ; Frumholtz, Laure ; Baroudjian, Barouyr ; Delyon, Julie ; Lebbe, Céleste ; Lambotte, Olivier</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3880-79de615f21f432b892595644898716ed5c241531173ef0a97dc47bb1de868c8a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Antibodies, Monoclonal, Humanized - adverse effects</topic><topic>Antibodies, Monoclonal, Humanized - therapeutic use</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Combined Modality Therapy</topic><topic>Fatal Outcome</topic><topic>Female</topic><topic>France - epidemiology</topic><topic>haematotoxicity</topic><topic>haemophagocytic lymphohistiocytosis</topic><topic>Hematology</topic><topic>Humans</topic><topic>Immune checkpoint</topic><topic>Immune Checkpoint Inhibitors - adverse effects</topic><topic>Immune Checkpoint Inhibitors - therapeutic use</topic><topic>Immunotherapy - adverse effects</topic><topic>Ipilimumab - adverse effects</topic><topic>Ipilimumab - therapeutic use</topic><topic>Life Sciences & Biomedicine</topic><topic>Literature reviews</topic><topic>Lymphohistiocytosis, Hemophagocytic - chemically induced</topic><topic>Lymphohistiocytosis, Hemophagocytic - epidemiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasms - drug therapy</topic><topic>Nivolumab - adverse effects</topic><topic>Nivolumab - therapeutic use</topic><topic>Science & Technology</topic><topic>tumour immunotherapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dupré, Anastasia</creatorcontrib><creatorcontrib>Michot, Jean‐Marie</creatorcontrib><creatorcontrib>Schoeffler, Amélie</creatorcontrib><creatorcontrib>Frumholtz, Laure</creatorcontrib><creatorcontrib>Baroudjian, Barouyr</creatorcontrib><creatorcontrib>Delyon, Julie</creatorcontrib><creatorcontrib>Lebbe, Céleste</creatorcontrib><creatorcontrib>Lambotte, Olivier</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dupré, Anastasia</au><au>Michot, Jean‐Marie</au><au>Schoeffler, Amélie</au><au>Frumholtz, Laure</au><au>Baroudjian, Barouyr</au><au>Delyon, Julie</au><au>Lebbe, Céleste</au><au>Lambotte, Olivier</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Haemophagocytic lymphohistiocytosis associated with immune checkpoint inhibitors: a descriptive case study and literature review</atitle><jtitle>British journal of haematology</jtitle><stitle>BRIT J HAEMATOL</stitle><addtitle>Br J Haematol</addtitle><date>2020-06</date><risdate>2020</risdate><volume>189</volume><issue>5</issue><spage>985</spage><epage>992</epage><pages>985-992</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><cop>HOBOKEN</cop><pub>Wiley</pub><pmid>32243578</pmid><doi>10.1111/bjh.16630</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-7201-6456</orcidid><orcidid>https://orcid.org/0000-0003-3482-3331</orcidid><orcidid>https://orcid.org/0000-0002-4557-3377</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-1048 |
| ispartof | British journal of haematology, 2020-06, Vol.189 (5), p.985-992 |
| issn | 0007-1048 1365-2141 |
| language | eng |
| recordid | cdi_wiley_primary_10_1111_bjh_16630_BJH16630 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Wiley Free Content |
| subjects | Adult Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Combined Modality Therapy Fatal Outcome Female France - epidemiology haematotoxicity haemophagocytic lymphohistiocytosis Hematology Humans Immune checkpoint Immune Checkpoint Inhibitors - adverse effects Immune Checkpoint Inhibitors - therapeutic use Immunotherapy - adverse effects Ipilimumab - adverse effects Ipilimumab - therapeutic use Life Sciences & Biomedicine Literature reviews Lymphohistiocytosis, Hemophagocytic - chemically induced Lymphohistiocytosis, Hemophagocytic - epidemiology Male Middle Aged Neoplasms - drug therapy Nivolumab - adverse effects Nivolumab - therapeutic use Science & Technology tumour immunotherapy |
| title | Haemophagocytic lymphohistiocytosis associated with immune checkpoint inhibitors: a descriptive case study and literature review |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T08%3A17%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_wiley&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Haemophagocytic%20lymphohistiocytosis%20associated%20with%20immune%20checkpoint%20inhibitors:%20a%20descriptive%20case%20study%20and%20literature%20review&rft.jtitle=British%20journal%20of%20haematology&rft.au=Dupr%C3%A9,%20Anastasia&rft.date=2020-06&rft.volume=189&rft.issue=5&rft.spage=985&rft.epage=992&rft.pages=985-992&rft.issn=0007-1048&rft.eissn=1365-2141&rft_id=info:doi/10.1111/bjh.16630&rft_dat=%3Cproquest_wiley%3E2409627550%3C/proquest_wiley%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2409627550&rft_id=info:pmid/32243578&rfr_iscdi=true |